Aggrastat

Iroko is pleased to announce its worldwide acquisition of AGGRASTAT® (tirofiban hydrochloride).

Iroko is an innovative, global company founded to acquire, develop, and maximize the potential of currently marketed pharmaceutical products. We are dedicated to becoming the premier source of trusted brand-name pharmaceutical products. Our renewed efforts will assure that high-quality, ethical products are easily accessed by healthcare providers and patients who can benefit most from their continued availability.

Please check back at this site often for more updates.

• To see the AGGRASTAT® Summary of Product Characteristics, please click here

• To request product-specific information, please email us at: productinfo@Iroko.com

• To report side effects or to contact Medical Affairs, please email us at: productinfo@Iroko.com